- OPKO Health (OPK) acquires Laboratorio Arama de Uruguay. Terms were undisclosed, with closing expected in Jan.
- CEO Phillip Frost: "This acquisition will allow OPKO to establish a footprint in Uruguay and facilitate future sales and commercial expansion into neighboring Argentina. In the near term, Arama provides another platform for the commercialization of our 4Kscore."
- OPK shares +4.9% AH
From other sites
at Nasdaq.com (Apr 9, 2015)
at Nasdaq.com (Mar 26, 2015)
at 4-traders.com (Mar 24, 2015)
at 4-traders.com (Mar 23, 2015)
at Nasdaq.com (Mar 12, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs